Table 2.
Inhibitors Code |
Cinh./ mol L−1 |
icor/ µAcm−2 ±SD |
Ecor/ mV (Ag/AgCl) ±SD |
βa/ mV dec −1 |
−βc/ mV dec −1 |
θ | ZPDP/% |
---|---|---|---|---|---|---|---|
Blank | 0.0 | 325.7 ± 24.2 | −640 | 95.2 | 170.2 | - | - |
FSG6-2 | 5 × 10−6 | 164.31 ± 14.5 | −651 | 100.8 | 166.8 | 0.495 | 49.55 |
1.5 × 10−5 | 138.71 ± 10.1 | −660 | 97.4 | 178.8 | 0.574 | 57.41 | |
3.0 × 10−5 | 87.09 ± 7.6 | −658 | 98.5 | 181.4 | 0.732 | 73.26 | |
6.0 × 10−5 | 70.51 ± 5.9 | −635 | 99.6 | 160.1 | 0.783 | 78.35 | |
1.0 × 10−4 | 46.60 ± 4.2 | −648 | 106.4 | 152.3 | 0.856 | 85.69 | |
2.0 × 10−4 | 21.59 ± 2.3 | −636 | 103.1 | 174.7 | 0.933 | 93.37 | |
FSG6-4 | 5 × 10−6 | 153.86 ± 13.7 | −645 | 99.7 | 180.3 | 0.527 | 52.76 |
1.5 × 10−5 | 127.38 ± 11.3 | −652 | 96.3 | 174.7 | 0.608 | 60.89 | |
3.0 × 10−5 | 67.77 ± 5.8 | −638 | 90.7 | 169.1 | 0.791 | 79.19 | |
6.0 × 10−5 | 47.19 ± 4.9 | −657 | 92.9 | 170.2 | 0.855 | 85.51 | |
1.0 × 10−4 | 28.75 ± 2.4 | −639 | 98.8 | 180.3 | 0.911 | 91.17 | |
2.0 × 10−4 | 10.61 ± 1.5 | −633 | 97.4 | 174.7 | 0.967 | 96.74 | |
FSG6-6 | 5 × 10−6 | 141.94 ± 13.6 | −642 | 98.5 | 162.4 | 0.564 | 56.42 |
1.5 × 10−5 | 110.86 ± 9.8 | −652 | 95.2 | 165.7 | 0.659 | 65.96 | |
3.0 × 10−5 | 54.97 ± 4.7 | −647 | 96.3 | 170.2 | 0.831 | 83.12 | |
6.0 × 10−5 | 36.93 ± 3.1 | −627 | 92.9 | 182.5 | 0.886 | 88.66 | |
1.0 × 10−4 | 17.81 ± 1.2 | −630 | 100.8 | 175.8 | 0.945 | 94.53 | |
2.0 × 10−4 | 5.31 ± 1.0 | −618 | 97.6 | 172.4 | 0.983 | 98.37 |